JMJD1C Antikörper (AA 150-200)
Kurzübersicht für JMJD1C Antikörper (AA 150-200) (ABIN1906272)
Target
Alle JMJD1C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 150-200
-
Spezifität
- Region between residue 150 and 200 of human Jumonji Domain Containing 1C using the numbering given in entry NP_004232.2 (GeneID 221037).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:500 - 1:2500), IHC, IHC-P (1:1000 - 1:5000), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Laryngeal Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Ovarian Carcinoma, Skin Squamous Cell Carcinoma.
Not recommended for: IP -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- JMJD1C (Jumonji Domain Containing 1C (JMJD1C))
-
Andere Bezeichnung
- JMJD1C
-
Hintergrund
-
Name/Gene ID: JMJD1C
Synonyms: JMJD1C, JHDM2C, Jumonji domain containing 1C, KIAA1380, TR-interacting protein 8, TRIP-8, RP11-10C13.2, TRIP8 -
Gen-ID
- 221037
-
Pathways
- Nuclear Hormone Receptor Binding
Target
-